Oruka Therapeutics Q1 EPS $(0.48) Beats $(0.55) Estimate
Benzinga Newsdesk 5 months ago
EarningsEarnings BeatsNews
Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent. This is a 20 percent decrease over losses of $(0.40) per share from
Oruka Therapeutics (NASDAQ:ORKA) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent. This is a 20 percent decrease over losses of $(0.40) per share from the same period last year.